Training Program in Human Investigation
Training Program in Human Investigation
批准号:
7125605
负责人:
SCOTT A WALDMAN
金额:
$30.0万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-09-30 至 2010-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: State the application's broad, long-termobjectivesand specific aims, makingreferenceto the health relatednessof the project. Describe
conciselythe researchdesign and methodsfor achievingthesegoals.Avoidsummariesof pastaccomplishmentsand the useof the first person. Thisabstract
is meant to serve as a succinct and accurate description of the proposedwork when separated from the application. If the application is funded, this
description, as is, will become public information.Therefore, do not include proprietary/confidentiailnformation. DO NOT EXCEED THE SPACE
PROVIDED.
Clinical investigators are disappearing from the ranks of federally funded research portfolios to the extent that they have
become an "endangered species". To counter this loss, the Training Program in Human Investigation at Thomas Jefferson
University prepares investigators for enduring careers pursuing funded hypothesis-driven patient-oriented research and to
be role models and mentors to subsequent investigators pursuing similar careers. This Clinical Research Curriculum is
composed of a multi-disciplinary faculty with expertise in patient-oriented research, a core of relevant courses and patient-
based research experiences, and mentored training in clinical investigation. Successful completion of the program requires
>40 course credits and a formal research thesis and defense. Applications are solicited from a large pool (>650) of trainees
drawn from different colleges within the university, as well as from clinical training programs at other health care centers in
Philadelphia. Eligible applicants include house officers and subspecialty fellows, dentists, pharmacy fellows with a
Pharm.D., Ph.D. fellows, and those with a doctoral degree in nursing interested in patient-oriented research. Applicants
submit a written application, three letters of recommendation, and transcripts and are selected by an Advisory Committee
following personal interviews. Once accepted, trainees pursue a unique program of didactic and applied research
components. Formal coursework provides training in essential topics for patient-oriented research including biostatistics,
epidemiology, clinical trial design, database management, outcomes research, bioethics and the responsible conduct of
research, clinical pharmacology, federal policy and regulations regarding human subjects, scientific writing and grant writing.
Coursework is supplemented with components that provide practical experience central to the conduct of patient-oriented
research. These include (1) a clerkship in the Jefferson Clinical Research Unit in which trainees participate in a mentored
clinical research experience by generating, implementing, completing, and reporting on a randomized clinical trial; and (2)
identification of an interest-specific thesis question and advisor, development of a thesis proposal, and conduct of thesis
research. Additional novel aspects of this training program include rotations on the Institutional Review Board (IRB)
and/or Cancer Clinical Research Review Committee (CCRRC) and a clerkship in the critical review of scientific literature
with the editorial staff of the Annals of Internal Medicine. Other important programmatic components include ethics
seminars and conferences, journal club in clinical investigation, an in-house research seminar series, and seminars in clinica]
investigation with invited speakers from outside the institution. Upon completion of the program, trainees have (1) a
thorough understanding of hypothesis formulation and testing in patient-based studies, (2) a theoretical foundation and
working knowledge of research designs, (3) insight into the integration of laboratory-based analyses and surrogate endpoints
in patient-oriented research, (4) a demonstrated record of achievement conducting randomized clinical trials and other types
of studies documented through publication, (5) the ability to critically evaluate the scientific literature, and (6) the ability to
employ various computer-based statistical and database packages in research-related. Upon completion of the program,
trainees are qualified to perform independent clinical research with certification through a Master's of Science in Human
Investigation.
PERFORMANCE SITE(S) (organization, city, state)
Thomas Jefferson University, Philadlephia, PA
Fox Chase Cancer Center, Philadelphia, PA
KEY PERSONNEL. See instructions. Use continuation pages as needed to provide the required information in the format shown below.
Start with Principal Investigator. List all other key personnel in alphabetical order, last name first.
Name Organization Role on Project
Waldman, Scott Thomas Jefferson University Director
Greenberg, Howard Thomas Jefferson University Associate Director
Leone, Frank Thomas Jefferson University Deputy Director
Weinberg, David Fox Chase Cancer Center Associate Director
Disclosure Permission Statement. Applicable to SBIR/STTR Only. See instructions.[] Yes [] No
PHS 398 (Rev. 05/01) Page 2 Numberpagesconsecutivelayt thebottomthroughout Form Page 2
theapplicationD. onotusesuffixessuchas2a,2b.
PrincipInavlestigator/ProgramDirector(Last, First, Middle):
Below is a list of Faculty and Advisory Committee who will be
they are not listed as key personnel, their Biographical Sketches
Name
Daskalakis, Constantine
Greenberg, Howard (Key Personnel)
Hauck, Waiter
Laine, Christine
Leone, Frank (Key Personnel)
Myers, Ronald
Nash, David
Tolosa, Jorge
Waldman, Scott (Key Personnel)
Weinberg, David (Key Personnel)
Buescher, Georganne
Chambers, Christopher
Curran, Waker
Falkner, Bonita
Goldberg, Barry
Goldstein, Barry
Novielli, Karen
Rabinowitz, Howard
Waldman, Scott A.
contributing to the Clinical Research Curriculum. Although
are attached.
Role on Project
Faculty
Faculty
Faculty
Faculty
Faculty
Faculty
Faculty
Faculty
Faculty
Faculty
Advisory Committee
Advisory Committee
Advisory Committee
Advisory Committee
Advisory Committee
Advisory Committee
Advisory Committee
Chairman, Advisory Committee
PHS 398 (Rev. 05/01) Page 3 Number pages consecutively at the bottom throughout Form Page 2
the application. Do not use suffixes such as 2a, 2b.
PrincipInavl estigator/PrDoigreracmt(oLrasFt,irsMt, iddle): Waldman, Scott A.
The name of the principal investigator/program director must be provided at the top of each printed page and each continuation page.
RESEARCH GRANT
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neuroprotection by the GUCY2C gut-brain axis in Parkinson's disease
-
批准号:10740951
-
项目类别:
-
资助金额:$42.9万
-
财政年份:2023
-
负责人:SCOTT A WALDMAN
-
依托单位:
Guanylin GUCY2C axis in Colorectal Cancer Initiation
-
批准号:9237630
-
项目类别:
-
资助金额:$37.2万
-
财政年份:2017
-
负责人:SCOTT A WALDMAN
-
依托单位:
(PQ1) GUCY2C hormone loss translates APC-Beta-catenin mutations into epithelial transformation
-
批准号:9922880
-
项目类别:
-
资助金额:$35.69万
-
财政年份:2016
-
负责人:SCOTT A WALDMAN
-
依托单位:
(PQ1) GUCY2C hormone loss translates APC-Beta-catenin mutations into epithelial transformation
-
批准号:9101320
-
项目类别:
-
资助金额:$35.69万
-
财政年份:2016
-
负责人:SCOTT A WALDMAN
-
依托单位:
GUCY2C hormone signaling at the intersection of obesity and colorectal cancer(PQ1
-
批准号:8680189
-
项目类别:
-
资助金额:$31.2万
-
财政年份:2012
-
负责人:SCOTT A WALDMAN
-
依托单位:
GUCY2C hormone signaling at the intersection of obesity and colorectal cancer(PQ1
-
批准号:8517056
-
项目类别:
-
资助金额:$30.23万
-
财政年份:2012
-
负责人:SCOTT A WALDMAN
-
依托单位:
GUCY2C hormone signaling at the intersection of obesity and colorectal cancer(PQ1
-
批准号:8895861
-
项目类别:
-
资助金额:$32.16万
-
财政年份:2012
-
负责人:SCOTT A WALDMAN
-
依托单位:
Occult lymph node metastases and racial disparities in colon cancer outcomes
-
批准号:7828432
-
项目类别:
-
资助金额:$49.85万
-
财政年份:2009
-
负责人:SCOTT A WALDMAN
-
依托单位:
Occult lymph node metastases and racial disparities in colon cancer outcomes
-
批准号:7941015
-
项目类别:
-
资助金额:$49.86万
-
财政年份:2009
-
负责人:SCOTT A WALDMAN
-
依托单位:
Guanylyl Cyclase C in Blood and Colorectal Cancer
-
批准号:6772420
-
项目类别:
-
资助金额:$120.43万
-
财政年份:2003
-
负责人:SCOTT A WALDMAN
-
依托单位:
Guanylyl Cyclase C in Blood and Colorectal Cancer
-
批准号:6685481
-
项目类别:
-
资助金额:$94.32万
-
财政年份:2003
-
负责人:SCOTT A WALDMAN
-
依托单位:
Guanylyl Cyclase C in Blood and Colorectal Cancer
-
批准号:7285005
-
项目类别:
-
资助金额:$4.47万
-
财政年份:2003
-
负责人:SCOTT A WALDMAN
-
依托单位:
Guanylyl Cyclase C in Blood and Colorectal Cancer
-
批准号:7289710
-
项目类别:
-
资助金额:$67.0万
-
财政年份:2003
-
负责人:SCOTT A WALDMAN
-
依托单位:
Guanylyl Cyclase C in Blood and Colorectal Cancer
-
批准号:6945900
-
项目类别:
-
资助金额:$136.97万
-
财政年份:2003
-
负责人:SCOTT A WALDMAN
-
依托单位:
Guanylyl Cyclase C in Blood and Colorectal Cancer
-
批准号:7481026
-
项目类别:
-
资助金额:$83.59万
-
财政年份:2003
-
负责人:SCOTT A WALDMAN
-
依托单位:
Guanylyl Cyclase C in Blood and Colorectal Cancer
-
批准号:7474877
-
项目类别:
-
资助金额:$5.42万
-
财政年份:2003
-
负责人:SCOTT A WALDMAN
-
依托单位:
CLINICAL PHARMACOLOGY TRAINING PROGRAM
-
批准号:6351098
-
项目类别:
-
资助金额:$8.73万
-
财政年份:2000
-
负责人:SCOTT A WALDMAN
-
依托单位:
CLINICAL PHARMACOLOGY TRAINING PROGRAM
-
批准号:6498480
-
项目类别:
-
资助金额:$18.63万
-
财政年份:2000
-
负责人:SCOTT A WALDMAN
-
依托单位:
TRAINING PROGRAM IN HUMAN INVESTIGATION
-
批准号:6388700
-
项目类别:
-
资助金额:$19.11万
-
财政年份:2000
-
负责人:SCOTT A WALDMAN
-
依托单位:
TRAINING PROGRAM IN HUMAN INVESTIGATION
-
批准号:6649665
-
项目类别:
-
资助金额:$19.69万
-
财政年份:2000
-
负责人:SCOTT A WALDMAN
-
依托单位:
海外基金